Labcorp Holdings (LH) Non-Current Deffered Revenue (2014 - 2015)
Labcorp Holdings (LH) posted Non-Current Deffered Revenue of $46.4 million for Q4 2015, up 1264.71% sequentially from $3.4 million in Q4 2014, and up 1264.71% YoY from $3.4 million in Q4 2014.
Labcorp Holdings (LH) Non-Current Deffered Revenue (2014 - 2015) Analysis & Trends
Labcorp Holdings has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $46.4 million in Q4 2015.
- Quarterly Non-Current Deffered Revenue rose 1264.71% year-over-year to $46.4 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $46.4 million (up 1264.71% YoY) and the FY2015 annual result came in at $46.4 million, up 1264.71% from the prior year.
- Non-Current Deffered Revenue climbed to $46.4 million in Q4 2015 per LH's latest filing, from $3.4 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $46.4 million in Q4 2015 and troughed at $3.4 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | - |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 32.59 Mn |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | - |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 17.00 Mn |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | - |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 46.40 Mn |
| Dec 31, 2014 | 3.40 Mn |